Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer.
Shang L, Zhang W, Wu H, Wu R, Chen R.
europepmc +1 more source
Predictive value analysis of CEA, CA125 and CYFRA21-1 levels in evaluating the efficacy of tislelizumab combined with gemcitabine-cisplatin chemotherapy in patients with advanced non-small cell lung cancer. [PDF]
Wang L, Gou T, Cui Y, Li M, Wang Y.
europepmc +1 more source
Assessment of diagnostic efficacy: High fluorescent cells combined with CEA, NSE, and Cyfra21-1 in Malignant Pleural Effusion Identification. [PDF]
Zhang N +8 more
europepmc +1 more source
CYFRA21-1/TG ratio as an accurate risk factor to predict eye metastasis in nasopharyngeal carcinoma: A STROBE-compliant article. [PDF]
Peng SJ +9 more
europepmc +1 more source
Clinical Significance of CYFRA21-1 as a Screening Test of Lung Cancer
openaire +2 more sources
Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1. [PDF]
Wang J, Tang X, Liu X, Zhang J.
europepmc +1 more source
CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis. [PDF]
Li B +10 more
europepmc +1 more source
Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy. [PDF]
Li L +9 more
europepmc +1 more source

